These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2008423)

  • 1. Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women.
    Prentice RL
    Prev Med; 1991 Jan; 20(1):147-57. PubMed ID: 2008423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planning the analysis of a breast cancer prevention trial.
    Moon TE
    Prev Med; 1991 Jan; 20(1):109-18. PubMed ID: 2008420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design issues for a breast cancer chemoprevention trial.
    DeMets DL; Newcomb PA; Carey P
    Prev Med; 1991 Jan; 20(1):101-8. PubMed ID: 2008419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment strategies for a possible tamoxifen trial.
    Kuller LH
    Prev Med; 1991 Jan; 20(1):119-24. PubMed ID: 1901168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective.
    Prentice RL
    Stat Med; 1990; 9(1-2):161-70; discussion 170-2. PubMed ID: 2345832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral dynamics of clinical trials.
    Leventhal H; Nerenz DR; Leventhal EA; Love RR; Bendena LM
    Prev Med; 1991 Jan; 20(1):132-46. PubMed ID: 2008422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study.
    Henderson MM; Kushi LH; Thompson DJ; Gorbach SL; Clifford CK; Insull W; Moskowitz M; Thompson RS
    Prev Med; 1990 Mar; 19(2):115-33. PubMed ID: 2193306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fat and breast cancer risk: the feasibility of a clinical trial of breast cancer prevention.
    Boyd NF; Cousins M; Lockwood G; Tritchler D
    Lipids; 1992 Oct; 27(10):821-6. PubMed ID: 1435102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizing multicenter trials: lessons from cardiovascular prevention trials.
    Furberg CD
    Prev Med; 1991 Jan; 20(1):158-61. PubMed ID: 2008424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of breast cancer in premenopausal women.
    Love RR
    J Natl Cancer Inst Monogr; 1994; (16):61-5. PubMed ID: 7999471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond HERS: some (not so) random thoughts on randomized clinical trials.
    Bush T
    Int J Fertil Womens Med; 2001; 46(2):55-9. PubMed ID: 11374656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations.
    Ballard-Barbash R; Hunsberger S; Alciati MH; Blair SN; Goodwin PJ; McTiernan A; Wing R; Schatzkin A
    J Natl Cancer Inst; 2009 May; 101(9):630-43. PubMed ID: 19401543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the breast: primary prevention of breast cancer by tamoxifen, eligibility criteria, alternatives to English proposals].
    Serin D
    Bull Cancer; 1995 Jul; 82 Suppl 3():168s-171s. PubMed ID: 7492829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical design of the Women's Health Trial.
    Self S; Prentice R; Iverson D; Henderson M; Thompson D; Byar D; Insull W; Gorbach SL; Clifford C; Goldman S
    Control Clin Trials; 1988 Jun; 9(2):119-36. PubMed ID: 3396363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients.
    Rose DP; Connolly JM; Chlebowski RT; Buzzard IM; Wynder EL
    Breast Cancer Res Treat; 1993 Sep; 27(3):253-62. PubMed ID: 8312583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary.
    Fisher B
    J Clin Oncol; 1999 May; 17(5):1632-9. PubMed ID: 10334553
    [No Abstract]   [Full Text] [Related]  

  • 18. Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial.
    Bush TL; Helzlsouer KJ
    Epidemiol Rev; 1993; 15(1):233-43. PubMed ID: 8405207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding more muscle and nerve to clinical trials.
    Conwit RA; Bhanushali MJ; Porter JD; Kaufmann P; Gutmann L
    Muscle Nerve; 2011 Nov; 44(5):695-702. PubMed ID: 22006684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for the prevention of breast cancer in high-risk women.
    Sweeney FW; Newton WP
    J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.